IP Verse

Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts - EP2588090

The patent EP2588090 was granted to Krka on Nov 22, 2023. The application was originally filed on Jul 1, 2011 under application number EP11732405A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2588090

KRKA
Application Number
EP11732405A
Filing Date
Jul 1, 2011
Status
Patent Maintained As Amended
Oct 20, 2023
Grant Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EDERJan 19, 2018EDERADMISSIBLE
GEORG KALHAMMERSTEPHAN TEIPELJan 19, 2018-ADMISSIBLE
GENERICS UKJan 16, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO03074056
DESCRIPTIONWO2005018615
DESCRIPTIONWO2005023249
DESCRIPTIONWO2005028468
DESCRIPTIONWO2009118321
DESCRIPTIONWO2009118322
DESCRIPTIONWO2010007016
DESCRIPTIONWO9837075
INTERNATIONAL-SEARCH-REPORTWO2009097156
INTERNATIONAL-SEARCH-REPORTWO2010007016
OPPOSITIONUS2003181488
OPPOSITIONWO03074056
OPPOSITIONWO2009097156
OPPOSITIONWO2010007016
OTHERWO2009097156
OTHERWO2010007016

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "2.8.3 Protamine sulphate", Anonymous, British National Formulary, BNF 56, BMJ Group, (20080900), page 2pp, 129, XP055510880-
OPPOSITION- "CHMP Assessment Report for Pradaxa", European Medicines Agency (EMEA), London, (20080000), pages 1 - 36, XP055003938-
OPPOSITION- C. NASTRUZZI et al., "Influence of Formulation and Process Parameters on Pellet Production by Powder Layering Technique", AAPS PharmSciTech, (20000000), vol. 1, no. 2, pages 1 - 12, XP003035615-
OPPOSITION- DEY N S; MAJUMDAR S; MEB RAO, "Multiparticulate drug delivery systems for controlled release", Tropical Journal of Pharmaceutical Research,, vol. 7, no. 3, (20080901), pages 1067 - 1075, XP002646988-
OPPOSITION- J. M. KANDUKURI et al., "Pelletization techniques for oral drug delivery", Int J Pharm Sci, (20090000), vol. 1, no. 2, pages 63 - 70, XP008159757-
OPPOSITION- MANIVANNAN et al., "MULTIPARTICULATE DRUG DELIVERY SYSTEM:PELLET& PELLETIZATION TECHNIQUE", Drug Invention Today, (20100501), vol. 2, no. 5, pages 233 - 237, XP003035614-
OPPOSITION- MANIVANNAN et al., "Multiparticulate drug delivery systems: Pellet and pelletization technique", Drug Invention Today, (20100501), vol. 2, no. 5, pages 233 - 237, XP003035614-
OPPOSITION- NASTRUZZI et al., "Influence of formulation and process parameters on pellet production by powder layering technique", AAPS PharmSciTech, (20000000), vol. 1, no. 2, pages 1 - 12, XP003035615-
OPPOSITION- NASTRUZZI et al., "INFLUENCE OF FORMULATION AND PROCESS PARAMETERS ON PELLET PRODUCTION BY POWDER LAYERING TECHNIQUE", AAPS PharmSciTech, (20000000), vol. 1, no. 2, pages 1 - 12, XP003035615-
OPPOSITION- R. MANIVANNAN et al., "Multiparticulate drug delivery systems: Pellet & pelletization technique", Drug Invention Today, (20100000), vol. 2, no. 5, pages 233 - 237, XP003035614-
OTHER- MANIVANNAN G.ET AL, "MULTIPARTICULATE DRUG DELIVERY SYSTEM:PELLET& PELLETIZATION TECHNIQUE", DRUG INVENTION TODAY, (201005), vol. 2, no. 5, pages 233 - 237, XP003035614-
OTHER- NASTRUZZI C . ET AL, "INFLUENCE OF FORMULATION AND PROCESS PARAMETERS ON PELLET PRODUCTION BY POWDER LAYERING TECHNIQUE", AAPS PHARMSCITECH, (2000), vol. 1, no. 2, pages 1 - 12, XP003035615-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents